COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 273.9 | 1 | 0050-0558 | 95.67 | 558.64 | 212 | 58.18 | 0.787 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.2 | 1 | 0051-0568 | 648.28 | 568.31 | 304 | 68.18 | 0.822 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 230.2 | 1 | 0052-0569 | 834.65 | 569.67 | 293 | 66.43 | 0.834 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.9 | 1 | 0053-0605 | 697.52 | 605.52 | 252 | 58.77 | 0.917 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 234.9 | 1 | 0054-0610 | 547.24 | 610.47 | 328 | 69.60 | 0.851 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 285.7 | 1 | 0055-0610 | 598.30 | 610.74 | 166 | 53.94 | 0.717 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 279.5 | 1 | 0056-0639 | 326.67 | 638.87 | 198 | 53.11 | 0.882 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 273.8 | 1 | 0057-0697 | 329.28 | 697.00 | 230 | 59.84 | 0.807 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 243.0 | 1 | 0058-0706 | 735.74 | 705.51 | 250 | 73.60 | 0.580 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 267.2 | 2 | 0001-0033 | 490.85 | 32.69 | 260 | 66.28 | 0.744 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.8 | 2 | 0002-0065 | 39.68 | 65.16 | 334 | 70.43 | 0.846 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.1 | 2 | 0003-0071 | 263.62 | 70.95 | 321 | 73.26 | 0.752 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 263.9 | 2 | 0004-0104 | 246.65 | 104.64 | 292 | 75.50 | 0.644 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 266.5 | 2 | 0005-0207 | 403.66 | 206.99 | 276 | 68.18 | 0.746 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 322.5 | 2 | 0006-0218 | 447.01 | 218.02 | 223 | 66.43 | 0.635 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 320.9 | 2 | 0007-0233 | 670.79 | 232.76 | 279 | 104.81 | 0.319 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.9 | 2 | 0008-0248 | 396.52 | 248.61 | 314 | 69.84 | 0.809 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 283.9 | 2 | 0009-0248 | 449.88 | 249.51 | 100 | 47.46 | 0.558 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 302.9 | 2 | 0010-0282 | 915.46 | 282.98 | 120 | 50.77 | 0.585 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 252.8 | 2 | 0011-0354 | 665.79 | 353.71 | 302 | 68.18 | 0.816 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 225.4 | 2 | 0012-0389 | 40.48 | 389.26 | 286 | 68.18 | 0.773 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 663.0 | 2 | 0013-0396 | 667.73 | 395.75 | 228 | 57.01 | 0.881 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 540.8 | 2 | 0014-0408 | 655.79 | 407.55 | 276 | 66.08 | 0.794 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 319.3 | 2 | 0015-0409 | 559.15 | 408.44 | 277 | 64.18 | 0.845 |
COLO 858 | Vemurafenib | 3.16 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.6 | 2 | 0016-0459 | 258.19 | 459.85 | 306 | 66.18 | 0.878 |